Aerobic Exercise Effects on Cognitive Function in Aging Individuals
Exploring the Impact of Supervised Treadmill Aerobic Exercise on Cognitive Function and Apoptotic-Related Biomarkers in Aging Individuals
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
Positive effects are exerted by participating in moderate exercise training with physical activity which positively affects body health, including cognitive abilities, among older adults. Thus, the investigators are trying to study the potential effects of the supervised aerobic training regimen for 12 weeks on cognitive function among older adults based on molecular changes in cellular apoptosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2013
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 25, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2014
CompletedFirst Submitted
Initial submission to the registry
October 7, 2024
CompletedFirst Posted
Study publicly available on registry
October 21, 2024
CompletedOctober 21, 2024
October 1, 2024
11 months
October 7, 2024
October 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Assessment of body weight as anthropometric measurements
the impact of exercise training program on body weight was identified pre and post exercise period. Weight measurements in kilograms from all participants were estimated by employing a standardized approach, utilizing a tape measure and a calibrated Salter Electronic Scale (Digital Pearson Scale; ADAM Equipment Inc., Columbia, MD, USA). The calculated weights were used to estimate BMI of each recpective participant.
3 month
Assessment of body height as anthropometric measurements
the impact of exercise training program on body height was identified pre and post exercise period. A standardized approach, utilizing a tape measure and a calibrated Salter Electronic Scale (Digital Pearson Scale; ADAM Equipment Inc., Columbia, MD, USA) were used to estimate body height of each participants. The values of body height in meters were used in combination with body weight to perform BMI of its respective participant.
3 month
Assessment of BMI as as anthropometric measurements
Assessment of body mass index ( BMI in kg/m\^2)as anthropometric measurements In this test, BMI from body weight and height measurements for each participant were estimated before and after exercise training interventions by using a bioelectrical impedance analysis (BIA) based body composition analyzer (TBF 105, Tanita Corporation, Tokyo, Japan)
3 month
Secondary Outcomes (4)
Assessment of cognitive abilities
3 month
Assessment of serum Bcl-2 as apoptotic-related protein
3 month
Assessment of serum cytochrome c as apoptotic-related protein
3 month
Assessment of serum p53 (pg/ml) as apoptotic-related protein
3 month
Study Arms (2)
the control group
NO INTERVENTIONnon-exercised participants with daily life activities
exercise group
EXPERIMENTALparticipants engaged in a 12-week exercise regimen structured thrice weekly.Each session's intensity was customized to match the individual's maximum and resting heart rates. The warm-up involved stretching and a 5 to 10-minute walk. In the core exercise phase, participants aimed to reach their predetermined training heart rate (THR max; between 60 to 70%) for 45-60 minutes through intervals on a treadmill, bike, or stair climber.The exercise protocol was designed to elicit physical exertion equivalent to 30-45% of their maximum oxygen consumption (VO2 max)
Interventions
In this training program, the participants exercised for 45-60 minutes through intervals on a treadmill, bike, or stair climber, three times a week for 12 weeks.
Eligibility Criteria
You may qualify if:
- home resident older
- healthy individuals
- the participants were aged between 65 and 95
You may not qualify if:
- Participants with Any physical impairments or conditions such as endocrine, immune, or psychiatric disorders
- participants with eating disorders
- participants' use of any glucocorticoid medications, which might impact the assessment of apoptotic and cognitive functions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical investigator
Study Record Dates
First Submitted
October 7, 2024
First Posted
October 21, 2024
Study Start
December 25, 2013
Primary Completion
November 30, 2014
Study Completion
December 30, 2014
Last Updated
October 21, 2024
Record last verified: 2024-10